Seeking Alpha

L'Oreal's (LRLCY.PK -0.5%) Lancome USA unit has received an FDA warning about the marketing of...

L'Oreal's (LRLCY.PK -0.5%) Lancome USA unit has received an FDA warning about the marketing of some of its anti-wrinkle products, saying the products are making claims suggesting they are drugs. Several skin care and eye rejuvenator products claim to "boost the activity of genes and stimulate the production of youth proteins" or provide "immediate lifting" to the eye area, which violate federal drug laws.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs